Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis
Open Access
- 27 November 2002
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (25) , 16203-16208
- https://doi.org/10.1073/pnas.212646299
Abstract
We analyzed gene expression patterns in human gastric cancers by using cDNA microarrays representing ≈30,300 genes. Expression of PLA2G2A, a gene previously implicated as a modifier of the ApcMin/+ (multiple intestinal neoplasia 1) mutant phenotype in the mouse, was significantly correlated with patient survival. We confirmed this observation in an independent set of patient samples by using quantitative RT-PCR. Beyond its potential diagnostic and prognostic significance, this result suggests the intriguing possibility that the activity of PLA2G2A may suppress progression or metastasis of human gastric cancer.Keywords
This publication has 41 references indexed in Scilit:
- Synovial-type (group II) phospholipase A2 human seminal plasmaAndrologia, 2009
- Chemotherapy options for gastric cancerSeminars in Radiation Oncology, 2002
- Expression of Group IIA Secretory Phospholipase A2 Is Elevated in Prostatic Intraepithelial Neoplasia and AdenocarcinomaThe American Journal of Pathology, 2002
- NSAIDs and Gastrointestinal Cancer PreventionDrugs, 2002
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- An OmpA-Like Protein fromAcinetobacterspp. Stimulates Gastrin and Interleukin-8 PromotersInfection and Immunity, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Group II and IV phospholipase A2 are produced in human pancreatic cancer cells and influence prognosisGut, 1999
- Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesisNature Genetics, 1997
- The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasiaCell, 1995